The new joint venture will bring K Health's artificial intelligence-driven technology to the consumer, employer and insurer markets. The solution enables patients to understand their symptoms and connect with a doctor if needed.
The Pennsylvania-based insurer is offering members using its small group products access to the NeuroFlow app, which provides self-guided activities to combat mental health issues.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
K Health raised $132 million in funding, which it plans to use to expand its platform into pediatric patients. The company has built a symptom-checker app and lets patients text a primary care physician for an additional fee.
Google rolled out a Health Studies app, a rival to Apple's research app. To start, it will offer a study on respiratory illness in conjunction with Harvard Medical School and Boston Children’s Hospital.
K Health, a startup building a symptom checker that allows users to compare their symptoms to similar patient cases, struck a partnership with Mayo Clinic’s Data Analytics Platform. It also raised another $42 million in funding as it builds out a telehealth platform.
Talkspace, which lets users message a therapist, acquired relationship counseling app Lasting. It hinted at plans for additional acquisitions in the future.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Early data showed that Zimmer Biomet’s MyMobility app yielded similar results to patients who received traditional care after knee surgery. Zimmer Biomet shared its findings from the randomized controlled clinical trial on Thursday.
The company reached an agreement to sell the health app to Francisco Partners after acquiring it for $475 million in 2015.
In a Thursday blog post, officials shared that the app’s “risk threshold” had been lowered to account for exposure to people when they are most infectious. The update was supposed to take place when the app was launched in late September.
Instead of suggesting a diagnosis for moles and skin lesions, digital health startup Miiskin is leaving that up to dermatologists. The company is rolling out a version of its tool for clinicians to make it easier for their patients to track moles and other spots on their skin.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Walmart acquired CareZone’s medication management technology and intellectual property. The purchase is the latest move by Walmart to compete with its pharmacy services.
Meditation app Headspace raised $47.7 million in funding, according to an SEC filing. The new funds come four months after Headspace closed a $93 million series C round.
An analysis of more than 100 Covid-19 apps by the International Digital Accountability Council found that many fell short of best practices for privacy and security. Some concerns including using third-party SDKs that were not core to the app’s functionality, and sending unencrypted transmissions.
Digital health startup raised a $90 million funding round led by Bessemer Venture Partners. The company builds software tools to help patients with joint and back pain.
Publicly-traded DarioHealth plans to use the cash to put its smartphone-based glucometer into the hands of insurers.